Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
- Revenue
- +6.92%
- EPS
- +3.18%
- Free cash flow
- +44.7%
- Total debt
- +3.21%
Quarter to September 2026, against a year earlier
Follow LH
Alert me
Labcorp Holdings Inc. (LH) Return on assets
Labcorp Holdings Inc.'s return on assets over the twelve months to 30 September 2026 was 5.40%, up 0.6 percentage points from fiscal 2025 (4.77%). Over the past ten years it has ranged from 2.27% (fiscal 2023) to 11.8% (fiscal 2021); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of −6.05% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 4.77% | 0.52 |
| FY2024 | 4.25% | 1.98 |
| FY2023 | 2.27% | (4.04) |
| FY2022 | 6.31% | (5.44) |
| FY2021 | 11.8% | 3.59 |
| FY2020 | 8.16% | 3.35 |
| FY2019 | 4.81% | (0.57) |
| FY2018 | 5.38% | (2.56) |
| FY2017 | 7.94% | 2.92 |
| FY2016 | 5.02% | 0.93 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | 25.6% |
| MEDP Medpace Holdings, Inc. compare | 25.5% |
| ILMN Illumina, Inc. compare | 13.8% |
| A Agilent Technologies, Inc. compare | 11.0% |
| DGX Quest Diagnostics Incorporated compare | 6.73% |
| LH Labcorp Holdings Inc. | 5.40% |
| IQV IQVIA Holdings Inc. compare | 4.71% |
| WAT Waters Corporation compare | 0.68% |
| GH Guardant Health, Inc. compare | −30.7% |
| Diagnostics & Research industry median | −6.05% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on LH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement